Corpus Intelligence IC Memo — BANNER PAYSON MEDICAL CENTER 2026-04-26 11:19 UTC
IC Memo — BANNER PAYSON MEDICAL CENTER
Investment Committee Memorandum | AZ | 25 beds | Grade C | EBITDA uplift $3.6M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

BANNER PAYSON MEDICAL CENTER

CCN 031318 | GILA, AZ | 25 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

BANNER PAYSON MEDICAL CENTER is a 25-bed suburban community hospital in GILA, AZ with $49.3M in net patient revenue and a 0.0% operating margin. The hospital serves a payer mix of 36.2% Medicare, 11.2% Medicaid, and 52.7% commercial.

Thesis: Turnaround. Our ML models identify $3.6M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 0.0% to 7.4% (+736bps).

Net Revenue HCRIS$49.3M
Current EBITDA COMPUTED$7K
Operating Margin COMPUTED0.0%
Occupancy HCRIS47.7%
Revenue / Bed COMPUTED$2.0M
Net-to-Gross HCRIS50.7%
Distress Probability ML51.7%

2. Market Context & Competitive Position

124
AZ Hospitals
-0.8%
State Median Margin
41
Comparable Hospitals

AZ has 124 Medicare-certified hospitals with a median operating margin of -0.8%. The target's margin of 0.0% places it above the state median. Among 41 size-comparable peers (12-50 beds), the median margin is -2.8%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (12-50), prioritizing same-state peers. 41 hospitals in the comp set.

HospitalStateBedsRevenueMargin
BANNER PAYSON MEDICAL CENTER (Target)AZ25$49.3M0.0%
ARIZONA GENERAL HOSPITALAZ50$116.2M-6.6%
ARIZONA GENERAL HOSPITALAZ16$97.1M10.4%
THE CORE INSTITUTE SPECIALTY HAZ28$91.2M9.2%
MT. GRAHAM REGIONAL MEDICAL CEAZ25$75.2M-2.8%
COBRE VALLEY REG. MEDICAL CENTAZ25$74.9M-10.3%
COPPER QUEEN COMM. HOSP.AZ14$63.5M6.6%
MT. GRAHAM REGIONAL MEDICAL CEAZ25$49.4M-6.8%
AZ SPINE & JOINT HOSPITALAZ23$45.1M19.4%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $3.6M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$1.0M+210bp18mo
Cost to Collect4.5%2.5%$986K+200bp12mo
Denial Rate Reduction12.0%6.5%$976K+198bp12mo
A/R Days Reduction5200.0%3800.0%$600K+122bp9mo
Clean Claim Rate88.0%96.0%$32K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$1.0M
Cost to Collect
$986K
Denial Rate Reduction
$976K
A/R Days Reduction
$600K
Clean Claim Rate
$32K
Total EBITDA Uplift$3.6M
Current EBITDA$7K
+ RCM Uplift+$3.6M
Pro Forma EBITDA$3.6M
Current Margin0.0%
Pro Forma Margin7.4%
WC Released (1x)$1.9M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$11K$36.3M3331.86x406.4%
Base (11x exit)10.0x11.0x$11K$40.0M3665.37x416.2%
Bull Case9.0x11.0x$10K$52.0M5293.10x455.6%
Bull (12x exit)9.0x12.0x$10K$56.7M5774.59x465.3%
Bear Case11.0x10.0x$12K$18.2M1516.13x332.7%
Bear (11x exit)11.0x11.0x$12K$20.0M1668.07x341.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighElevated distress probabilityModel estimates 51.7% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 41 hospitals with 12-50 beds
  • Same-state prioritization (n=42)
  • Comp margins: P25=-10.1% / P50=-2.8% / P75=8.2%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.